SCHEMBL13567969

SCHEMBL13567969

CC(C)[C@@H]1CC[C@@H](C)CC1OC(=O)N1C(=S)N[C@@](C)(c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)nc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.37
MAPK1 P28482 4/20 0.37
KMT2A Q03164 3/20 0.37
MITF O75030 2/20 0.37
HTT P42858 2/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP19A1 P11511 2/20 0.36
TRPV1 Q8NER1 2/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 1/20 0.36
EPHX1 P07099 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 1/20 0.33
ACLY P53396 1/20 0.33
PDE1C Q14123 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13567906 0.95 NPSR1 (0.37) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567904 0.95 NPSR1 (0.37) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13568025 0.89 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567929 0.89 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567930 0.89 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13568026 0.89 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567983 0.88 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567989 0.88 NPSR1 (0.38) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567940 0.87 NPSR1 (0.37) NPSR1MAPK1KMT2AMITFHTT
SCHEMBL13567939 0.87 NPSR1 (0.37) NPSR1MAPK1KMT2AMITFHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 NPSR1 4055/4885MAPK1 1186/4885KMT2A 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.